Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Zidoval 7.5 mg/g vaginal gel.
| Pharmaceutical Form |
|---|
|
Vaginal gel. A colourless to straw coloured gel. |
Metronidazole 0.75% w/w, 7.5 mg/g.
Excipients with known effect:
Methyl parahydroxybenzoate (E218) 0.8 mg/g.
Propyl parahydroxybenzoate (E216) 0,2 mg/g.
Propylene glycol (E1520) 30.0 mg/g.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Methronidazole |
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
| List of Excipients |
|---|
|
Carbomer (Carbopol) 974P |
Aluminium tubes lined with an epoxy phenolic resin with polyethylene screw caps containing 40 g product. The product is packaged with 5 disposable vaginal applicators, each to deliver 5 g of gel.
Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
PL 46302/0153
31 January 1997 / 15 February 2010
| Drug | Countries | |
|---|---|---|
| ZIDOVAL | Finland, Israel, Malta, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
